JDOCvsPBE
JPMorgan Healthcare Leaders ETF against Invesco Dynamic Biotechnology & Genome ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| JDOC | PBE | |
|---|---|---|
| Expense ratio | 0.65% | 0.58% |
| Assets | $8911.98T | $414M |
| Net flow, 1 month | — | +$15M |
| Net flow, 1 year | −$25K | +$114M |
| Return, YTD | +2.9% | +15.7% |
| Return, 1 year | +9.4% | +30.8% |
| Avg daily volume | 229 | 13K |
| Holdings | 67 | 31 |
| Listed | Oct 31, 2023 | Jun 23, 2005 |
| Options market | No | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS